Plus Therapeutics (PSTV) Misses Q2 EPS by 71c
Tweet
Share
E-mailGet Alerts PSTV Hot Sheet
Join SI Premium – FREE
Plus Therapeutics (NASDAQ: PSTV) reported Q2 EPS of ($0.71). Revenue for the quarter came in at $1.27 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stran & Company, Inc. (SWAG) Reports Q2 EPS of $0.02
- Mount Logan Capital Inc. (MLCI) Reports Q2 Loss of $0.37
- Barclays Upgrades Arkema SA (AKE:FP) (ARKAF) to Equalweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
